Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results reported from the ADVANCE IV clinical trial, which was conducted globally, including at Georgetown University Medical Center.
Xavier Allamigeon, a researcher in mathematics and IT at the Saclay Centre, has been awarded the Inria - French Academy of Sciences Young Researchers Prize. This is in recognition of his endeavours in a high-level discipline known as tropical geometry. The theoretical results in mathematical optimisation from his research have attracted interest from the scientific community, but his research also has a range of more concrete applications which could be of benefit to society as a whole.
Researchers examined the prevalence of contraindications to nirmatrelvir-ritonavir (Paxlovid) in hospitalized coronavirus disease 2019 (COVID-19) patients.